MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 31.0221

Change

-0.25 (-0.81)%

Market Cap

N/A

Volume

253.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
ACWI iShares MSCI ACWI ETF

+0.45 (+0.38%)

USD 19.10B
IBIT iShares Bitcoin Trust

+0.24 (+0.67%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

N/A

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.16 (+0.29%)

USD 16.09B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 3.07B
IBTF iShares iBonds Dec 2025 Term T..

-0.01 (-0.04%)

USD 2.07B
IBTE iShares iBonds Dec 2024 Term T..

N/A

USD 2.06B
PABU iShares Paris-Aligned Climate ..

+0.26 (+0.41%)

USD 2.05B
NVDL GraniteShares 1.5x Long NVDA D..

+0.14 (+0.26%)

USD 2.05B
USCL iShares Climate Conscious & Tr..

+0.24 (+0.36%)

USD 2.01B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.07% 68% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.07% 66% D+ 67% D+
Trailing 12 Months  
Capital Gain 5.20% 44% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.20% 39% F 49% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.35% 52% F 44% F
Dividend Return 0.35% 45% F 40% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 1.21% 97% N/A 100% F
Risk Adjusted Return 28.42% 55% F 61% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector